2026. Development of Stimuli-Responsive Nanoparticles for Targeted Delivery of Encorafenib in BRAF-Mutant Cancer Therapy. International Journal of Research Development and Technology. 4, 1 (Mar. 2026), 85–109. DOI:https://doi.org/10.62218/ijrdt.v4i1.170.